TRAVERE THERAPEUTICS INC

Ticker: TVTX CUSIP: 89422G107 Class: Common Stock

MARSHALL WACE, LLP's Holding History (CIK: 0001318757)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 217,171 Value ($000) $8,298 Avg Close $32.52 Range $23.22 - $42.13

Q3 2025

Shares 590,051 Value ($000) $14,102 Avg Close $18.80 Range $14.36 - $28.69

Q2 2025

Shares 742,725 Value ($000) $10,992 Avg Close $16.57 Range $12.91 - $22.07

Q3 2024

Shares 111,341 Value ($000) $1,558 Avg Close $10.42 Range $7.72 - $15.36

Q3 2023

Shares 73,332 Value ($000) $656 Avg Close $14.11 Range $7.00 - $17.57

Q1 2023

Shares 214,498 Value ($000) $4,824 Avg Close $21.26 Range $17.82 - $23.18

Q4 2021

Shares 6,866 Value ($000) $213 Avg Close $28.16 Range $23.73 - $31.65

Q3 2021

Shares 52,307 Value ($000) $1,268 Avg Close $18.37 Range $12.75 - $25.78

Q1 2021

Shares 174,193 Value ($000) $4,349 Avg Close $27.63 Range $22.39 - $33.09

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	217,171	$8,298	$32.52	$23.22 - $42.13
Q3 2025	590,051	$14,102	$18.80	$14.36 - $28.69
Q2 2025	742,725	$10,992	$16.57	$12.91 - $22.07
Q3 2024	111,341	$1,558	$10.42	$7.72 - $15.36
Q3 2023	73,332	$656	$14.11	$7.00 - $17.57
Q1 2023	214,498	$4,824	$21.26	$17.82 - $23.18
Q4 2021	6,866	$213	$28.16	$23.73 - $31.65
Q3 2021	52,307	$1,268	$18.37	$12.75 - $25.78
Q1 2021	174,193	$4,349	$27.63	$22.39 - $33.09